XML 36 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 18 - Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information [Table Text Block]
   

Three Months Ended

 
   

March 31,

2014

   

June 30,

2014

   

September 30,

2014

   

December 31,

2014

 
   

(in thousands, except per share amounts)

 

Revenue

  $ 60,061     $ 68,436     $ 78,335     $ 75,703  

Cost of revenue

    27,964       31,337       35,872       34,744  

Gross profit

    32,097       37,099       42,463       40,959  

Operating expenses:

                               

Research and development

    15,603       13,368       14,679       14,941  

Selling, general and administrative

    16,109       16,853       17,006       16,787  

Litigation expense (benefit), net

    (8,700 )     274       332       66  

Total operating expenses

    23,012       30,495       32,017       31,794  

Income from operations

    9,085       6,604       10,446       9,165  

Interest and other income, net

    190       295       202       407  

Income before income taxes

    9,275       6,899       10,648       9,572  

Income tax provision (benefit)

    257       502       (573 )     712  

Net income

  $ 9,018     $ 6,397     $ 11,221     $ 8,860  
                                 

Net income per share:

                               

Basic

  $ 0.23     $ 0.17     $ 0.29     $ 0.23  

Diluted

  $ 0.23     $ 0.16     $ 0.28     $ 0.22  

Weighted-average shares outstanding:

                               

Basic

    38,470       38,684       38,785       38,807  

Diluted

    39,517       39,608       39,727       40,321  
                                 

Cash dividends declared per common share

  $ -     $ 0.15     $ 0.15     $ 0.15  
   

Three Months Ended

 
   

March 31,

2013

   

June 30,

2013

   

September 30,

2013

   

December 31,

2013

 
   

(in thousands, except per share amounts)

 

Revenue

  $ 51,470     $ 57,714     $ 65,347     $ 63,560  

Cost of revenue

    24,085       26,786       30,053       29,266  

Gross profit

    27,385       30,928       35,294       34,294  

Operating expenses:

                               

Research and development

    12,123       12,478       12,643       12,487  

Selling, general and administrative

    13,258       13,793       13,891       13,683  

Litigation expense (benefit), net

    (301 )     (257 )     104       84  

Total operating expenses

    25,080       26,014       26,638       26,254  

Income from operations

    2,305       4,914       8,656       8,040  

Interest and other income (expense), net

    (10 )     218       (59 )     (57 )

Income before income taxes

    2,295       5,132       8,597       7,983  

Income tax provision (benefit)

    (204 )     (357 )     1,187       484  

Net income

  $ 2,499     $ 5,489     $ 7,410     $ 7,499  
                                 

Net income per share:

                               

Basic

  $ 0.07     $ 0.15     $ 0.20     $ 0.20  

Diluted

  $ 0.07     $ 0.14     $ 0.19     $ 0.19  

Weighted-average shares outstanding:

                               

Basic

    36,259       37,053       37,910       38,328  

Diluted

    37,708       38,239       39,009       39,524  
                                 

Cash dividends declared per common share

  $ -     $ -     $ -     $ -